Virtu Financial LLC Cassava Sciences Inc Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$12.64 - $30.11 $339,055 - $807,670	26,824 Added 120.27%	49,128 $1.11 Million
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $371,138 - $564,737	22,304 New	22,304 $371,000
Q4 2022 Feb 15, 2023	SELL	$27.82 - $44.16 $85,240 - $135,306	-3,064 Reduced 23.38%	10,044 $297,000
Q3 2022 Nov 07, 2022	BUY	$16.33 - $51.06 $214,053 - $669,294	13,108 New	13,108 $548,000
Q3 2021 Nov 12, 2021	SELL	$41.79 - $135.3 $362,193 - $1.17 Million	-8,667 Closed	0 $0
Q2 2021 Sep 17, 2021	SELL	$32.15 - $89.72 $868,178 - $2.42 Million	-27,004 Reduced 75.7%	8,667 $741,000
Q1 2021 May 19, 2021	BUY	$7.09 - $87.95 $252,907 - $3.14 Million	35,671 New	35,671 $1.6 Million
Q3 2019 Nov 20, 2019	SELL	$1.04 - $1.45 $21,535 - $30,025	-20,707 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$1.02 - $1.34 $8,744 - $11,487	8,573 Added 70.65%	20,707 $25,000
Q1 2019 Apr 12, 2019	BUY	$0.92 - $1.29 $11,163 - $15,652	12,134 New	12,134 $16,000

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $94.2M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.